pmc logo imageJournal ListSearchpmc logo image
Logo of brheartjJournal URL: redirect3.cgi?&&auth=0XkjnZH_-jmek31AvjL1dK06VfDWPcA3j-j_l9A0g&reftype=publisher&artid=481167&article-id=481167&iid=15267&issue-id=15267&jid=160&journal-id=160&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=159&action=archive
Br Heart J. 1982 May; 47(5): 490–494.
PMCID: PMC481167
Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study.
I A Baker, R Eastham, P C Elwood, M Etherington, J R O'Brien, and P M Sweetnam
Abstract
In the Speedwell study set up to examine primarily the relation of plasma lipids and ischaemic heart disease in men aged 45 to 64 years drawn randomly from the practices of 16 general practitioners, various haemostatic factors which may contribute both to thrombogenesis and atherogenesis were measured. Fibrinogen measured nephelometrically and plasma viscosity were positively associated with the prevalence of ischaemic heart disease. Antithrombin III was negatively associated with the prevalence of ischaemic heart disease. These associations were statistically significant at the 1% level of probability. Fibrinogen measured by a clotting method and the heparin neutralising activity of platelet poor plasma had negative and positive associations with ischaemic heart disease, respectively, but neither association achieved statistical significance. Because of the interrelation of these variables and also age, a multiple logistic regression analysis was undertaken separately for the two measures of fibrinogen. The negative association of "clottable' fibrinogen and the positive association of plasma viscosity with the prevalence of ischaemic heart disease were confirmed and both were statistically significant at the 5% level of probability. Apart from age the independent association of the other variables with ischaemic heart disease did not achieve statistical significance. Fibrinogen measured by both methods had positive and statistically significant associations with serum total cholesterol, but no associations with serum total triglycerides, smoking, or alcohol consumption. "Clottable' fibrinogen had an inverse and statistically insignificant association with serum high density lipoprotein cholesterol. The observed associations support the concept of the involvement of some haemostatic factors in the aetiology of ischaemic heart disease, and these associations are now being examined more critically in a longitudinal study.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (819K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • CRAWFORD, T; LEVENE, CI. The incorporation of fibrin in the aortic intima. J Pathol Bacteriol. 1952 Jul;64(3):523–528. [PubMed]
  • WOOLF, N. The distribution of fibrin within the aortic intima. An immunohistochemical study. Am J Pathol. 1961 Nov;39:521–532. [PubMed]
  • Carstairs, KC. The identification of platelets and platelet antigens in histological sections. J Pathol Bacteriol. 1965 Jul;90(1):225–231. [PubMed]
  • Smith, EB; Staples, EM; Dietz, HS; Smith, RH. Role of endothelium in sequestration of lipoprotein and firbrinogen in aortic lesions, thrombi, and graft pseudo-intimas. Lancet. 1979 Oct 20;2(8147):812–816. [PubMed]
  • Jorgensen, L; Haerem, JW; Chandler, AB; Borchgrevink, CF. The pathology of acute coronary death. Acta Anaesthesiol Scand Suppl. 1968;29:193–201. [PubMed]
  • Moncada, S; Vane, JR. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull. 1978 May;34(2):129–135. [PubMed]
  • Ross, R; Glomset, J; Kariya, B; Harker, L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1207–1210. [PubMed]
  • Bainton, D; Burns-Cox, CJ; Elwood, PC; Lewis, B; Miller, NE; Morgan, K; Sweetnam, PM. Prevalence of ischaemic heart disease and associations with serum lipoproteins in subjects aged 45 to 64 years. The Speedwell study. Br Heart J. 1982 May;47(5):483–489. [PubMed]
  • CLAUSS, A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957 Apr;17(4):237–246. [PubMed]
  • Thorp, JM; Horsfall, GB; Stone, MC. A new red-sensitive micronephelometer. Med Biol Eng. 1967 Jan;5(1):51–56. [PubMed]
  • Harkness, J. The viscosity of human blood plasma; its measurement in health and disease. Biorheology. 1971 Dec;8(3):171–193. [PubMed]
  • Von Kaulla, E; Von Kaulla, KN. Antithrombin 3 and diseases. Am J Clin Pathol. 1967 Jul;48(1):69–80. [PubMed]
  • Mancini, G; Carbonara, AO; Heremans, JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. [PubMed]
  • O'Brien, JR; Etherington, M; Jamieson, S; Lawford, P; Sussex, J; Lincoln, SV. Heparin neutralizing activity test in the diagnosis of acute myocardial infarction. J Clin Pathol. 1975 Dec;28(12):975–979. [PubMed]
  • Hampton, JW; Mantooth, J; Brandt, EN; Wolf, SG., Jr Plasma fibrinogen patterns in patients with coronary atherosclerosis. Circulation. 1966 Dec;34(6):1098–1101. [PubMed]
  • Pilgeram, LO. Turnover rate of autologous plasma fibrinogen-14C in subjects with coronary thrombosis. Thromb Diath Haemorrh. 1968 Nov 15;20(1):31–43. [PubMed]
  • Meade, TW; Chakrabarti, R; Haines, AP; North, WR; Stirling, Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J. 1979 Jan 20;1(6157):153–156. [PubMed]
  • Korsan-Bengtsen, K; Wilhelmsen, L; Tibblin, G. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction. Thromb Diath Haemorrh. 1972 Aug 31;28(1):99–108. [PubMed]
  • O'Brien, JR. "Exhausted" platelets continue to circulate. Lancet. 1978 Dec 16;2(8103):1316–1317. [PubMed]
  • O'Brien, JR; Etherington, MD; Jamieson, S; Lawford, P; Lincoln, SV; Alkjaersig, NJ. Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis. Thromb Diath Haemorrh. 1975 Nov 15;34(2):483–497. [PubMed]
  • Okuno, T; Crockatt, D. Platelet factor 4 activity and thromboembolic episodes. Am J Clin Pathol. 1977 Apr;67(4):351–355. [PubMed]
  • Ross, R. Atherosclerosis: the role of endothelial injury, smooth muscle proliferation and platelet factors. Triangle. 1976;15(2-3):45–51. [PubMed]